The Cure To Fasting Headaches
And no, it’s not ‘eat something’
Pharmaceutical company Merck thinks it has solved your Yom Kippur headache—and that its infamous drug Vioxx, which was the subject of a massive recall and class-action settlement, is involved. The anti-headache drug, marketed as Arcoxia, is a Vioxx cousin. In studies, people who took it the night before a night and day of fasting experienced either no headache or a reduced headache (as compared to those who took the placebo), and found it easier to fast. Arcoxia is available in several European countries as well as Israel. Stateside, however, it is hard to come by: the Food and Drug Administration refused to approve it, on the grounds that it is too similar to its black-sheep cousin. Dunno—it certainly beats suppositories!
Could Vioxx Cousin Prevent Yom Kippur Headache? [Reuters/Vos Iz Neias?]
Daily rate: $2
Monthly rate: $18
Yearly rate: $180
WAIT, WHY DO I HAVE TO PAY TO COMMENT?
Tablet is committed to bringing you the best, smartest, most enlightening and entertaining reporting and writing on Jewish life, all free of charge. We take pride in our community of readers, and are thrilled that you choose to engage with us in a way that is both thoughtful and thought-provoking. But the Internet, for all of its wonders, poses challenges to civilized and constructive discussion, allowing vocal—and, often, anonymous—minorities to drag it down with invective (and worse). Starting today, then, we are asking people who'd like to post comments on the site to pay a nominal fee—less a paywall than a gesture of your own commitment to the cause of great conversation. All proceeds go to helping us bring you the ambitious journalism that brought you here in the first place.
I NEED TO BE HEARD! BUT I DONT WANT TO PAY.
Readers can still interact with us free of charge via Facebook, Twitter, and our other social media channels, or write to us at email@example.com. Each week, we’ll select the best letters and publish them in a new letters to the editor feature on the Scroll.
We hope this new largely symbolic measure will help us create a more pleasant and cultivated environment for all of our readers, and, as always, we thank you deeply for your support.